Finance

Lists
1737:TPE
Taiyen Biotech Co Ltd
NT$29.60
-0.17%
(-0.050) 1D
Nov 19, 1:30:30 PM GMT+8  ·   TWD
All symbols
SymbolPriceChange% Change
Generating top insights for 1737...
Open
NT$29.65
High
NT$29.65
Low
NT$29.45
Mkt. cap
5.92B
Avg. vol.
164.64K
Volume
206.75K
Dividend
4.73%
Quarterly dividend
NT$0.35
Ex-dividend date
Aug 24, 2026
P/E ratio
15.77
52-wk high
NT$32.50
52-wk low
NT$29.30
EPS
NT$1.88
Shares outstanding
200.00M
No. of employees
487
Open
NT$29.65
High
NT$29.65
Low
NT$29.45
Mkt. cap
5.92B
Avg. vol.
164.64K
Volume
206.75K
Dividend
4.73%
Quarterly dividend
NT$0.35
Ex-dividend date
Aug 24, 2026
P/E ratio
15.77
52-wk high
NT$32.50
52-wk low
NT$29.30
EPS
NT$1.88
Shares outstanding
200.00M
No. of employees
487
News stories
From web sources and news partners
About Taiyen Biotech Co Ltd
CEO-
Employees487
FoundedMar 1952
Headquarters-
SectorConsumer Staples
IndustryFood
Previous reportsAll values in TWD
Loading Previous Earnings...
Revenue
Net income
All values in TWD
Dec 2025
Mar 2026
Jun 2026
Sep 2026
Revenue
816.45M
789.50M
769.01M
825.05M
Cost of goods sold
493.63M
470.53M
476.19M
526.20M
Cost of revenue
495.58M
470.53M
476.19M
526.20M
Research and development expenses
15.37M
12.16M
12.76M
13.75M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
218.67M
185.31M
204.20M
197.81M
Operating expense
189.14M
197.47M
216.96M
211.61M
Total operating expenses
684.72M
668.00M
693.14M
737.80M
Operating income
131.73M
121.50M
75.87M
87.24M
Other non operating income
22.69M
-7.03M
11.26M
-6.87M
EBT including unusual items
168.21M
119.21M
92.73M
79.67M
EBT excluding unusual items
164.10M
120.68M
90.82M
79.67M
Income tax expense
25.12M
24.75M
13.11M
20.08M
Effective tax rate
14.94%
20.77%
14.14%
25.20%
Other operating expenses
-
-
-
-
Net income
143.09M
94.46M
79.62M
59.60M
Net profit margin
17.53%
11.96%
10.35%
7.22%
Earnings per share
-
-
-
-
Interest and investment income
6.07M
4.22M
6.08M
-
Interest expense
-784.00K
-772.00K
-2.14M
-702.00K
Net interest expenses
5.29M
3.45M
3.93M
-702.00K
Depreciation and amortization charges
-
-
-
-
EBITDA
194.59M
185.10M
139.29M
158.30M
Gain or loss from assets sale
2.41M
-
12.00K
3.72M
Upcoming events
AI content may include mistakes. Learn more
Google apps